Company / PP&E per Share
ORAMED PHARMACEUTICALS INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2025
5-year range
$0.01 / $0.02
FY2021-FY2025
Trend
-15.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.02 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +20.8%.
Declined from $0.02 to $0.01 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -11.7%
- 5-Year CAGR
- +20.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share decreased 15.2% year-over-year.
- Peak pp&e per share was recorded in FY2023.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -15.2% |
| FY2024 | $0.02 | -21.6% |
| FY2023 | $0.02 | +3.3% |
| FY2022 | $0.02 | +27.4% |
| FY2021 | $0.02 | +194.4% |
| FY2020 | $0.01 | +312.2% |
| FY2019 | $0.00 | +11.1% |
| FY2018 | $0.00 | -8.9% |
| FY2017 | $0.00 | -1.3% |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026